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1. Introduction
The World Health Organization estimates that 10% of the world’s population over the age of
60 suffers from osteoarthritis (OA) [1]. The majority of these cases involve the hip and knee.
Symptomatic osteoarthritis of the ankle with radiographic changes is seen in approximately
11% of patients seeking treatment for “arthritis” [1]. Idiopathic arthritis, as seen in the hip
and knee, is rare in the ankle joint. The majority of ankle arthritis is secondary to trauma
(70%), with a smaller percentage being attributed to inflammatory arthropathies such as RA
(12%) and only 7% attributed to primary OA [2]. Ankle arthritis can be a debilitating dis‐
ease. In fact, the mental and physical disability associated with end-stage arthritis of the an‐
kle is at least as severe as that associated with end stage hip arthritis [3].
1.1. Anatomy
The ankle joint consists of the tibio-talar joint incorporating articular surfaces between the
talar dome with the tibial plafond, and the medial talus with the medial malleolus. In addi‐
tion, there is an articulation between the lateral talus with the lateral malleolus. It is mainly a
rolling joint with congruent surfaces at high loads, allowing it to withstand large pressures
[1]. The ankle carries 5 times body weight during normal walking activities [4]. The majority
of the load (75%) is distributed across the tibio-talar joint but some force is transmitted
through the medial and lateral sides [5]. Pathological conditions such as a mal-united ankle
fracture results in changes in the contact stresses and the overall contact area [5].
1.2. History
Patients with arthritic changes to the ankle have the typical “arthritic” complaints as seen in
other affected joints. Patients often present with pain, swelling and stiffness. The pain may
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be worse with weight bearing/impact activities, with weather changes, and may wake them
at night. Painful symptoms may be worse with initiation of activities (especially first thing
in the morning) but may improve during the activity. The pain usually intensifies with pro‐
longed activity and after the activity is completed. Stiffness can be present, usually worse
first thing in the morning or after a prolonged rest. Swelling can be particularly bothersome
and is usually intermittent. Patients complain of pain in the anterior talo-crural area and
have difficulty with reciprocal stair climbing and hills. Subfibular or lateral foot pain is not
common and is more typical for patients with subtalar arthritis which may be seen in combi‐
nation with ankle arthritis. Patients with subtalar arthritis complain of difficulties with
walking on uneven ground.
Given that most ankle arthritis is post-traumatic, a history of previous trauma should be de‐
termined including a history of severe or repetitive ankle sprains [6]. History of previous in‐
fection is important to ascertain as it can be a contraindication to joint arthroplasty and
current infection should be treated immediately with antibiotics and possibly debridement.
Systemic illness such as rheumatoid arthritis, gout, and hemophilia should be noted. Pa‐
tients with diabetes mellitus can present with Charcot deformity including arthritis.
1.3. Physical exam
Patients should be inspected for general lower limb alignment, including the knees, ankle,
hindfoot, midfoot and forefoot, paying particular attention to varus/valgus mal-alignment of
the hindfoot and dorsiflexion/plantarflexion mal-alignment of the ankle. Inspection should
note any swelling about the ankle, wasting of the calf musculature and previous surgical in‐
cisions. Gait should be observed. Patients generally have a foreshortened stance phase, and
may walk with their foot externally rotated. Patients with ankle arthritis walk with a shorter
stride length, reduced walking speed, and a shorter stance phase of the affected limb [4, 5, 7,
8]. Active and passive range of motion should be compared to the other side for ankle dorsi/
plantar flexion and subtalar eversion/inversion. In severe ankle arthritis, it is important to
differentiate range of motion coming from the ankle joint as opposed to the hindfoot and
midfoot joints. Heel eversion and inversion may also show restrictions of movement. Palpa‐
tion should include all bone prominences and the anterior margin of the ankle joint looking
for areas of tenderness or synovitis. Sensory changes or motor dysfunction should be noted
for possible neurological abnormalities. Both dorsalis pedis and posterior tibial pulses
should be assessed along with capillary refill and any abnormalities may require further
vascular investigations with ABI and/or CT angiogram.
1.4. Imaging
Standard radiographs should include WEIGHTBEARING AP/Lateral and mortise views of
both ankles, and AP and lateral views of the foot. Radiographs can be reviewed for the clas‐
sic signs of OA including loss of joint space, subchondral sclerosis, cyst formation and osteo‐
phyte formation. CT scan can be useful to determine arthritic changes in adjacent joints, or
to look at the surrounding bone stock when considering arthroplasty but this technique is
compromised for diagnosing early OA with cartilage loss because it is not done in the
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weightbearing position; therefore it can be misleading regarding joint space maintenance
and overall joint alignment. MRI is not required when assessing ankle arthritis. If there is a
past history of infection, quiescent infection should be ruled out with a bone/gallium scan
combination or a white blood cell scan.
2. Conservative treatment
2.1. Medications
Non-steroidal anti-inflammatories drugs (NSAIDs) have long been the mainstay for sympto‐
matic treatment of arthritic joint pain. These drugs control the pain of arthritis but are not
disease modifying agents. Current classes of drugs include standard NSAIDs (eg. Ibuprofen,
Naproxen, Indomethacin). The newer Cox 2 inhibitors [eg. Celecoxib (Celebrex) and Rofe‐
coxib (Vioxx)] have less gastrointestinal side effects [9, 10]; however, concern about higher
risks of myocardial infarction, thrombosis and stroke lead to withdrawl of Rofecoxib (Vioxx)
from the market in 2004 Patients with long term NSAID use are counseled to have blood
pressure and kidney function checked regularly with their family physicians as all NSAIDS
still put patients at risk for renal-related complications.
Nutraceuticals such as glucosamine sulphate and chondroitin sulphate are popular non-pre‐
scription remedies. There have been a multiple studies on these products, the vast majority
done in the arthritic knee population. Findings include pain modification similar to NSAIDS
with a similar side effect profile, although the onset is slower [11, 12]. Other studies suggest
actual disease modification with long term glucosamine use, as seen by NON progression of
joint space narrowing [13, 14]. More recent authors have found no difference between glu‐
cosamine and placebo [15] and no evidence of disease modification or pain relief [16]. Popu‐
lar dosing for glucosamine is 1.5 grams per day.
2.2. Injections
Corticosteroids demonstrate both anti-inflammatory response and immunosuppressive ef‐
fect. After intra-articular administration, there is a decrease in erythema, swelling, heat and
tenderness. This may be secondary to altered movement and function of leucocytes, reduced
micro vascular dilation and permeability, and reduced prostaglandin synthesis. Side effects
can include septic arthritis, tendon rupture, post injection wheal and flare, facial flushing,
atrophic skin changes, toxic effect on cartilage (at large doses) and possible systemic absorp‐
tion. Standard limit of injections in weight bearing joints is 3-4 injections per year [17].
Hyaluronic acid (HA) is a major component of synovial fluid, and comprises part of the
structure of hyaline cartilage. Viscosupplementation by injection of HA derivatives (as avail‐
able in pharmaceutical components) has multiple proposed mechanisms of action. Biologic
effects include an anti-inflammatory as well as anti-oxidant effect, and restoration of endog‐
enous synthesis via positive feedback loop. Viscoelastic properties include a “mechanical
spongy” trapping of immune complexes and inflammatory cells and restoration of synovial
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fluid viscosity and elasticity. Multiple versions of HA exist from multiple pharmaceutical
companies. Not all are available in all countries [18]. Some examples of currently available
products include Hyalgan (sodium hyaluronate; Sanofi-Aventis, Bridgewater, NJ, USA),
Synvisc (hylan GF-20; Genzyme Corportation, Cambridge, MA, USA), Supartz (sodium hya‐
luronate; Smith & Nephew, London, UK), Orthovisc (high molecular weight hyaluronan;
Anika Therapeutics, Inc., Bedford, MA, USA), Euflexxa (1% sodium hyaluronate; Ferring
Pharmaceuticals, Inc., Saint-Prex, Switzerland), and Durolane (stabilize hyaluronic acid;
Smith & Nephew, York, UK). Most require multiple injections although newer ones (eg Dur‐
olane) are coming to market that require only one injection. Side effect of HA injections are
rare but include anaphylaxis, pseudogout type reaction, and Severe Acute Inflammatory Re‐
action (SAIR) which presents like septic arthritis.
The effectiveness of hyaluronic acid derivatives in the ankle joint has not been determined
due to poorly conducted studies with mixed results from the few good studies performed
[19, 20] although a recent randomized control trial article comparing HA to saline in the an‐
kle showed no therapeutic benefit from the HA injection. Both HA and Saline injection re‐
sulted in similar changes in VAS, AOS and AOFAS scores [21]. Further high quality studies
need to be completed before a definitive recommendation for HA derivatives in the ankle
can be given.
2.3. Bracing
There is a paucity of any literature on bracing and shoe modifications. Practically, bracing
progresses from a simple lace-up ankle brace to a more elaborate rigid Ankle Foot Orthosis
(AFO) (Figure 1). A rigid AFO works by restricting painful ankle range of motion.
Figure 1. Photograph of a rigid AFO.
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More severely affected joints may be helped by a clamshell AFO (offloading AFO) (Figure
2). This type of orthosis works by transferring weight from the ankle to the calf using the
clamshell portion that wraps around the calf (similar in principle to a patellar-tendon brace).
This type of AFO can have a hinge to maintain ankle range of motion or can be rigid to re‐
strict motion as well as off-load the joint.
 
Figure 2. Offloading AFO with a hinge. Picture on the left demonstrates the AFO in a separated condition while the
right picture shows it applied to the patient.
Some patients may benefit from shoe modifications such as a rocker bottom shoe (Figure 3).
This provides increased toe-off, thereby stressing the ankle joint less.
Figure 3. Forefoot rocker bottom shoe.
3. Surgical options
After non-operative treatments have been exhausted, surgical treatments can be considered.
These options will depend on the location and extent of the arthritis.
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3.1. Focal joint abnormalities
Localized lesions within the ankle joint can progress to generalized osteoarthritis. As docu‐
mented in the knee, larger lesions have a worse prognosis than smaller lesions [22, 23]. Smaller
lesions (usually considered 1cm2 or less can be asymptomatic or often are dealt with by arthro‐
scopic debridement of loose cartilage with or without microfracture technique. If there is un‐
derlying bone necrosis, removal of this bone and overlying damaged cartilage can provide
symptomatic relief. For larger lesions, the surgical options become more complicated and less
predictable. There are a variety of techniques that can be used but no specific technique has
been shown to superior to the rest. The most basic and economical procedure is microfacture.
This technique can be used to induce local mesenchymal stem cells to influx to the defect and
produce a fibrocartilage repair surface that can function well, particularly in the short to medi‐
um term [24, 25],. Although most research has been performed in the knee, this can be success‐
ful in the ankle as well  [26,  27].  Of the more complicated procedures, perhaps the most
publicized is autologous chondrocyte implantation (ACI) first described in 1994 in the knee
[28]. It is also performed in the ankle [29]. Although there is a lot of literature published on this
technique in the knee, the inability to reproduce the complex nature of the articular matrix has
led to further investigation into variations of the technique including matrix-associated chon‐
drocyte implantation (MACI) [30, 31] and characterized chondrocyte implantation (CCI) [32].
Both of these techniques attempt to improve on the quality of matrix formed during the proce‐
dure. Other techniques utilize intact matrix to replace damaged matrix. This ensures the com‐
plex structure of the matrix is maintained. These techniques include osteochondral autograft
transplantation (OATS) [33, 34] and mosaicplasty [35]) [36, 37], and bulk osteochondral allog‐
rafts [38-41]. Finally, other more experimental techniques such as synthetic scaffolds and mes‐
enchymal stem cells have been tried with variable success [42-45].
3.1.1. Cell-based techniques
Microfracture – Microfracture is a well-established technique for full thickness cartilage de‐
fects with an intact subchondral bone plate. The cartilage is debrided to form a well-con‐
tained defect with stable margins. The underlying bone is perforated with a sharp awl or
pick at 3-4mm intervals while ensuring a stable subchondral plate remains intact to support
the incoming cells. The perforations should penetrate deep enough to allow mesenchymal
stem cells from the underlying spongy bone to enter the defect. The blood that emerges
from the bone forms a clot and the stem cells differentiate into chondrocytes and fibrochon‐
drocytes to produce a fibrocartilage that fills the defects.
Post-operatively, the patient is allowed early ROM but should be non-weight bearing for a
period of time to allow some tissue formation. The length of time depends on the size and
location of the lesion. Advantages of this technique include that it is one operation with low
cost. Disadvantages include that fibrocartilage instead of hyaline cartilage is formed, filling
of the defect is unpredictable and often incomplete [46]. That said, if good results can be ob‐
tained, the results in the ankle may not deteriorate over time [27]. This is considered a first
line treatment by many surgeons, especially those that do not have access to the more com‐
plicated and expensive exogenous cell- or tissue-based therapies.
Arthroplasty - Update344
Autologous Chondrocyte Implantation (ACI and its analogues) – ACI is the most publicized tech‐
nique for repairing/regenerating pure cartilage defects in the knee joint. First popularized by
Brittberg in 1994 [28], thousands of patients have been treated using this technique in the
knee joint but far fewer in the ankle joint. Studies in the ankle have reported good inter‐
mediate- and long-term results [47, 48]. Despite the historical background and extensive use,
the technique has been modified to incorporate a matrix (MACI) or utilizing specific chon‐
drocytes from the harvest (CCI) in an attempt to improve results. This suggests that the re‐
sults from ACI are not optimal. ACI is a complicated technique that entails removing a
portion of cartilage from a relative non-weight bearing portion of the joint and sending it to
a lab for processing. Typically the donor cartilage is harvested from the ipsilateral knee joint
[47, 48]. The ankle joint is typically not used as no specific safe area has been clearly defined
[49]. During processing, the cells are removed from the matrix and expanded up to 20 mil‐
lion cells over a period of 3-4 weeks. The cells are then re-implanted at a second surgical
procedure. This entails opening the joint, preparing the defect by making sure it has well-
defined margins with an intact subchondral plate to prevent the intrusion of mesenchymal
stem cells from the bone. A periosteal flap is harvested from a nearby area and sutured over
the defect leaving a small area for injection of the expanded cells. The cells are injected un‐
der that flap that is then closed and sealed with fibrin glue. Often, a malleolar osteotomy is
required to gain access to areas of the talar dome.
MACI is the next generation of ACI that incorporates the use of a scaffold [50-52]. The proce‐
dure is similar to that of ACI except that a matrix is used instead of a periosteal flap. The
matrix is impregnated with the cells and shaped to the size of the defect. It is inserted and
fixed by different mechanisms. Advantages of this technique include that it can be done ar‐
throscopically in some cases and does not require the extra step of harvesting and suturing
the periosteal flap. Thus it is less invasive. It has not been shown to be conclusively better
than ACI. CCI (characterized chondrocyte implantation) is almost exactly the same as ACI
except that the laboratory preselects specific cells that the company believes are predisposed
to form articular cartilage out of all those that are harvested. These are the cells that are then
expanded and re-implanted with the theory that the identified subpopulation of chondro‐
cytes will produce a more physiologically intact matrix. The disadvantage of this technique
is some patients do not have sufficient cells that meet the criteria for an enhanced popula‐
tion and, therefore, are not candidates for this procedure.
The results  for  these  procedures  have generally  been good.  Concerns  with  these  proce‐
dures include that two separate surgical procedures are required and the cell processing
can  be  prohibitively  expensive.  These  major  concerns  limit  their  availability,  especially
when  they  have  not  been  conclusively  shown  to  be  superior  to  other  techniques  [53].
The uncertainties of these techniques have led some researchers to investigate the use of
mesenchymal  stem  cells  instead  of  chondrocytes.  This  would  allow  the  surgery  to  be
completed at one time and may produce young chondrocytes that could potentially pro‐
duce a  more robust  cartilage.  These techniques are  in  the more experimental  stage and
more commonly used in the knee joint.
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3.1.2. Tissue-based techniques
Osteochondral autograft transplantation is a technique developed for small to medium sized
defects. It consists of harvesting osteochondral plugs from less weight bearing portions of
the same joint (or a different joint such as the knee when dealing with the ankle) and im‐
planting them into the defect. This is accomplished by using 6mm diameter reamers to a
depth of 10-15mm into the subchondal bone. A corresponding osteochondral core is harvest‐
ed from another area and gently impacted into the newly formed defect attempting to ach‐
ieve a press-fit while maintaining the contour of the articular surface. With lesions larger
than 6mm diameter (ie most lesions that require treatment), multiple cores are required and
press-fit with an interdigitating method and termed mosaicplasty. Once again, there are
some reported good results using this technique [33, 36, 37, 54] but this is a complicated
technique with multiple drawbacks. Harvesting cores from the ankle is usually not possible,
therefore another joint must be violated and the harvest sites are not without possible com‐
plications such as knee pain and instability [35, 55]. Typically an osteotomy is required to
gain access to the talar dome because the plugs must be inserted perpendicular to the sur‐
face of the joint. Alignment of the multiple plugs is difficult to ensure a smooth surface and
the cartilage from the harvest often is of different thickness compared to the insertion site
resulting in a variable underlying subchondral bone. Obtaining precise contour matching
for lesions on the “shoulder” of the talus can be extremely difficult. Bone plugs of only 6mm
diameter are susceptible to fracture resulting in unstable fixation and the boundary between
the transplanted cartilage and native cartilage heals with fibrocartilage.
Osteochondral allografts can be done orthotopically and can be used for partial or whole
joint replacement procedures. Popularized by Gross in the 1970’s, these allografts were typi‐
cally fresh and used for all types of defects in many joints including those defects due to tu‐
mours and trauma. Historically, these grafts were used in defects that consisted of bone and
cartilage but can be used for cartilage-only defects as well. Good to excellent medium- and
long-term results have been reported [38-41, 56] but the use of this technique became re‐
stricted as concerns regarding transmission of infectious diseases became more prevalent.
Considering that this is not a life threatening disorder, the risk of transmission of infectious
diseases does not seem warranted (although disease transmission has been very rarely re‐
ported) and this method is rarely used. To decrease the risk by allowing more time for test‐
ing, hypothermic storage at 4°C was developed and allows the tissues to be stored for 28-42
days prior to transplantation. Unfortunately, cellular deterioration tends to begin after 7-14
days [57, 58]. Given that regulatory clearance takes about 14 days, the viability of the cells
within the tissue may not be as healthy as those in fresh allograft or in autograft. Investiga‐
tions have been ongoing to develop storage techniques that eliminate the possibility of infec‐
tious disease transmission and tissue deterioration over time while enabling the creation of a
large tissue bank for ready access. Recently we have developed a cryopreservation techni‐
que that can store the tissue indefinitely without deterioration and this may improve access
to the tissue required for this technique [59]. Despite the limitations of hypothermic storage,
there has been a resurgence of osteochondral allografting in recent years. This is the only bi‐
ologic technique that can resurface whole joints [60, 61] and has been quite successful for
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partial joint replacements [40, 62]. Bugbee et al [60] have published promising results in total
ankle arthroplasty using osteochondral allografts and similar procedures have been per‐
formed in Europe [61] but further improvements are required.
3.2. Early osteoarthritic changes
Once osteoarthritic changes become evident, cell based cartilage resurfacing techniques be‐
come less relevant due to the generalized nature of the process. There are some surgical techni‐
ques that can be used to palliate symptoms depending on the location and severity of the
arthritis.
Exostectomies – Occasionally impingement symptoms can be a significant component of ar‐
thritis pain. This usually occurs with anterior osteophytes off the distal tibia or talar neck.
Occasionally these osteophytes can form around the malleoli. When impingement pain is a
prominent feature, removal of the osteophytes, either open or arthroscopically, can be per‐
formed with significant improvement of symptoms. The exostectomy can include only the
osteophytes itself or also part of the arthritic articular surface leaving only healthier cartilage
tissue (Figure 4).
 
Figure 4. Left image shows preoperative lateral radiograph demonstrating anterior tibial and talar neck osteophytes.
Right image shows intraoperative fluoroscopic image after anterior tibial and talar neck exostectomies.
Osteotomies – Occasionally the osteoarthritis is more severe in one portion of the joint. This is
often medial or lateral. Offloading the arthritic portion of the joint with a closing (Figure 5),
opening wedge osteotomy (Figure 6) or a dome osteotomy (Figure 7) can also provide some
symptomatic relief [63-65].
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Distraction arthroplasty – Recently, some investigation has gone into determining the effect of
distraction arthroplasty. Joint distraction using an external fixator can alter the internal joint
environment and possibly improve joint function. Early results are promising, even with
more advanced osteoarthritis, but much more work needs to be completed [66].
 
Figure 5. Radiographic images of medial closing wedge osteotomy after a distal tibial-fibular fusion resulted in lateral
joint overload. Right image is an intraoperative fluoroscopic view after fixation with a compression staple.
 
Figure 6. Radiographic images of a medial opening wedge osteotomy after open reduction and internal fixation re‐
sulted in a varus malunion. The distal screws were removed from the original plate and an opening wedge osteotomy
was performed using an interposition plate.
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 Figure 7. Dome osteotomy of the distal tibia. Original radiograph show severe valgus malunion due to a growth ar‐
rest after an open fracture as a child. The dome osteotomy was performed to incorporate the tibia and fibula and
rotate the joint as a whole. Medial joint has been fully corrected while the lateral joint remains elevated due to intra-
articular incongruity.
3.3. Global osteoarthritis
Once the osteoarthritis becomes global and more severe, the treatment options become more
limited. The mainstay of treatment for end-stage ankle arthritis is ankle fusion although syn‐
thetic total joint arthroplasty is becoming more common as will be discussed. In addition,
total ankle arthroplasty allografting is an experimental technique that has recently been de‐
veloped that may be used in select cases.
Ankle  fusion  is  the  mainstay  treatment  for  end-stage  ankle  arthritis.  It  has  been  per‐
formed for over 130 years [67] and there are research stucies that demonstrate the long-
term  effectiveness  [68,  69].  Complications  of  ankle  fusion  include  nonunion,  malunion,
infection, nerve injury, persisting pain, loss of ankle range of motion, limp, and arthritis
of surrounding joints due to overload [70, 71]. Ankle fusion entails removing all of the re‐
maining  articular  cartilage  from  the  joint  as  well  as  the  underlying  subchondral  bone
leaving exposed cancellous bone. The surfaces are shaped so that there is  excellent con‐
tact between the talar dome and the tibial plafond. Most techniques incorporate the medi‐
al malleolus as a medial buttress while some also include the lateral malleolus. Once the
surfaces are prepared, internal fixation (occasionally external fixation) is applied. Postop‐
erative splinting in either an aircast or plaster cast is employed for 6-12 weeks with non-
weight bearing from 1-12 weeks depending on bone quality and rigidity of fixation and
progression of fusion radiographically.
Over the years, many techniques have been described with increasing success with regards
to fusion rates. Successful fusion rates can be expected to range from 86-100% depending on
patient characteristics and surgical techniques [68, 72-83]. The most commonly used techni‐
ques utilize internal fixation. This can be completed using anterior, lateral or posterior ap‐
proaches. Fixation can be achieved using crossed screws, plate and screws or an
intramedullary nail. Another more recent method includes the joint debridement achieved
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arthroscopically with percutaneous screw fixation. Alternatively, external fixation using
standard external fixation techniques or Ilizarov can be used after open joint debridement.
Traditionally, open techniques using an anterior approach going either medial or just lateral
to the tibialis anterior tendon have been used. This approach typically provides access to the
medial and superior aspects of the joint [75, 77]. This technique can be employed in ankles
that do not have much structural deformity. Once the articular surfaces are properly pre‐
pared, the talus is compressed into the medial axilla and fixed by a variety of measures in‐
cluding crossed screws [76] (Figure 8), plate and screws [75, 77] or external fixation/Ilizarov
[79, 80] (Figure 9). Less commonly, an intramedullary ankle arthrodesis nail can be used for
fixation but this must also cross the subtalar joint [78, 83] (Figure 10).
 
Figure 8. Left image showing severe OA changes but relatively normal structureal anatomy. Right image show fusion
using crossed screws with the second screw entering the lateral process of the talus and crossing the joint pushing the
talus into the medial axillay of the ankle mortice to achieve extra stability.
 
Figure 9. Total ankle replacement complicated by infection. Right image shows ankle replacement removed and at‐
tempt fusion using spanning external fixator.
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 Figure 10. Severe Charcot arthropathy in an obese diabetic patient. Limb salvage ankle fusion using an ankle arthrod‐
esis nail.
In ankles with more significant deformation, especially with bone loss, a more extensive ap‐
proach may be considered. This entails a lateral approach and employs a fibular osteotomy ap‐
proximately 5-6cm above the syndesmosis [72, 82] (Figure 11). The fibula is osteotomized
obliquely over a 1cm distance and displaced from the tibia using anterior dissection while leav‐
ing an intact posterior hinge. The distal fibular segment is split sagitally and the inner ½ re‐
moved so that the other ½ (still attached by the posterior soft tissue hinge) can be used as a
lateral buttress plate across the joint. Through this lateral incision, the surfaces of the talus and
tibial plafond can be prepared for the fusion. This can be supplemented by a small anterior me‐
dial incision over the medial gutter for that surface preparation. This approach allows contour‐
ing of the fusion surfaces to achieve good bone apposition and to correct mal-alignment. Often
supplemental bone graft is required to fill eroded defects. Fixation can be carried out by screws
including two screws from the fibular strut into either the tibia and the talus or the tibia alone
(to allow talar compression during weightbearing postoperatively).
 
Figure 11. First 2 images on the left show attempted fusion using inadequate screw fixation with screws barely cross‐
ing the fusion site while the fibula was left intact despite screws inserted across it. Revision fusion demonstrating the
use of the distal fibula as a strut plate graft with proper screw placement to achieve fusion.
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Some  surgeons  prefer  the  posterior  approach  to  the  ankle  for  fusion  [84-86].  This  ap‐
proach  can  be  through  or  beside  the  Achilles  tendon  and  can  provide  good  exposure
while minimizing risk to compromised anterior soft tissues when present. This approach
can be extended to incorporate the subtalar joint in the fusion mass and a blade plate is
often used for fixation.
In the circumstances of infection or soft tissue compromise, alternative approaches should be
considered. The ankle joint can be adequately debrided with minimal invasiveness using ar‐
throscopy [79, 87, 88] potentially decreasing soft tissue complications. Alternative fixation such
as external fixators [78] or the Ilzarov [83] can be used to limit the issues of hardware insertion
during ongoing infection. These devices may also be able to correct deformity over time.
As noted, ankle fusion can provide excellent relief of pain with significant improvement of
function [89]. Surgical techniques have advanced such that it should be expected to have a
90-100% fusion rate in uncomplicated cases. Meticulous soft tissue handling and intraopera‐
tive care can mitigate complications. Despite these results, ongoing concerns of limitations
of ankle motion and the increased stress on surrounding joints resulting in increased inci‐
dence of arthritis has led to the development of the total ankle arthroplasty as will be dis‐
cussed in the next section.
4. Arthroplasty implants
4.1. Historical perspective
Total ankle arthroplasties were first introduced in the 1970s [90]. The first prosthesis, created
by Lord and Marotte, was designed as an inverted total hip replacement [91]. Although
Lord and Marotte’s primary results were failures, over the next 20 years, more than 23 de‐
signs were developed using that generation's technology from hip and knee replacements
characterized by cemented, two component, constrained implants [92]. Despite good initial
results using this technology, there were problems with component loosening, severe osteol‐
ysis, infection, impingement and soft tissue breakdown [93, 94]. Kitaoka reviewed results of
the first generation TAR that included three studies with greater than 5 year follow-up and
found a 41% revision rate [95]. The high rate of failure for these first generation implants
and difficult salvage procedures tempered enthusiasm and led to questions as to whether
the ankle joint could be replaced successfully [92, 95-97]. Hintermann accurately stated, “in
an era of joint replacement surgery, ankle procedures have failed to achieve what has been
accomplished with other joints” [98].
The first generation implants were designed without proper understanding of ankle bio‐
mechanics  [99,  100].  The ankle  was assumed to  be a  hinge joint  and the rotational  and
translational  motions  were  not  recreated  which  lead  to  loosening  [97,  101].  These  im‐
plants were either highly constrained or unconstrained. The highly constrained implants
led to large shear and rotational  forces  that  were distributed through a small  joint  sur‐
face and even smaller prosthesis interface [94, 102, 103]. The unconstrained implants were
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unstable due to lack of attention to soft tissue balancing and failure to address soft tissue
impingement [94, 104, 105].
In general, ankle arthroplasties were implanted through an anterior approach to the ankle
but the importance of the soft tissue envelope was underestimated and excess traction on
the skin led to wound complications [92, 93]. The guides, jigs and instruments were not well
designed and sizing was inaccurate so implants were mal-positioned and malleolar frac‐
tures were common [92]. Patients were left with mal-aligned implants either because the an‐
gular deformity was not corrected at the time of surgery [5] or because the ligaments were
ignored leading to problems with functional mal-alignment despite good intraoperative po‐
sitioning [94, 102]. Finally, most implants were cemented and required large bone resection
including up to 17mm on the tibial side and 7mm on the talar side. This caused the implant
to be cemented into soft cancellous bone which was unable to support the bone cement in‐
terface [92, 106]. Subsidence was further exacerbated by non-anatomically shaped, under‐
sized implants [5, 92, 93, 107]. The aggressive bone resection of the tibia also changed the
level of the ankle axis causing alterations in the ankle biomechanics [5]. When function was
assessed via gait analysis, there was not as much improvement as had been anticipated. Gait
analyses of the first generation implants revealed that patients were subconsciously protect‐
ing the joint by not bearing weight normally across the ankle despite denying pain and were
not using normal ankle dorsiflexion in the stance phase despite adequate passive dorsiflex‐
ion on physical exam [4, 5, 106].
4.2. Biomechanical considerations
In order to understand the reasons for failure and to design a better total ankle arthroplasty,
it was important to understand the biomechanics of the foot and ankle. The ankle is a highly
constrained joint that does not function as a simple hinge joint because the axis is oblique
extending further plantar and posterior on the lateral side. This creates eversion with dorsi‐
flexion and inversion with plantarflexion [108]. Further, the axis of rotation changes
throughout the range of motion so that when the ankle moves from a plantarflexed to a dor‐
siflexed position there is a combination of distraction, sliding and compression [108, 109]. Fi‐
nally, there are rotational and translational movements that also need to be recreated with a
replacement arthroplasty [94, 110].
The most important concepts in the design of an ankle arthroplasty are constraint and con‐
gruency. Constraint can be defined as the resistance of an implant to a particular degree of
freedom of motion such as anterior-posterior translation or axial rotation [94]. In highly con‐
strained implants such as a hinged ankle replacement, all axial torque forces are translated
through the bone-prosthesis interface as shear forces that can lead to component loosening
[92, 111]. Congruency or conformity can be defined as the closeness of fit of the various com‐
ponents of the implant [92, 94]. In a fully conforming implant, the articular surface of the
tibia has the same radius of curvature as the articulating surface of the talus in both anterior-
posterior and medial-lateral directions. This decreases the wear rate because the polyethy‐
lene contact stress remains below the fatigue threshold for delamination and pitting [92]. In
a partially conforming or incongruent implant the round talus articulates with a flat tibia or
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there are differences in the radius of curvature of the 2 surfaces [92]. The optimal design for
a total ankle replacement is with bearing surfaces that are not only highly conforming to en‐
sure contact throughout the bearing surface thus reducing wear but also sufficiently con‐
strained to give the implant sufficient inherent stability to minimize shear stresses at the
prosthesis-bone interface [94, 112].
Second generation implants used these two concepts to improve the design of total ankle ar‐
throplasties. In general, the two primary alternatives were 1) a two component, partially con‐
forming ankle replacement which replaced all three articulations by changing the ankle into a
two bone joint by fusing the distal tibia-fibular joint [5, 92] or 2) a three component design
which resurfaced the tibio-talar joint and the talar side of the lateral and medial gutters [5, 92].
Third generation implants are more anatomically designed and rely on ligament support as
well as hindfoot “balancing” to allow the components to recreate the ankle biomechanics [113].
Gait studies of the newer implants show a satisfactory recovery of the natural overall mobi‐
lity of the ankle joint in all three planes of motion [114]. Further, in three component de‐
signs, there may be some movement of the polyethylene separate from the other
components which helps to restore normal biomechanics [114]. Functional motion and mus‐
cle-generated moments during walking improved at the ankle joint after arthroplasty – es‐
pecially plantar flexor muscle function. This function is important because it restrains the
forward movement of the tibia during the first half of the gait cycle and brings about plan‐
tarflexion of the ankle during the propulsive phase of gait [99]. Brodsky has shown signifi‐
cant improvement in velocity, step length for operated side, total ankle ROM during gait,
and maximum sagittal ankle joint power at push-off [115].
4.3. Current implants
Lewis has described key aspects for a successful ankle joint arthroplasty based on careful
review of the first and second generation implants [97]. It is important that implant size
be designed to balance the need for minimal bone resection with the requirement for suf‐
ficient implant to distribute stresses over a large area to decrease the risk of subsidence
[97].  The  anatomical  axis  needs  to  be  recreated  while  also  understanding  that  there  is
large variability in the axis between individuals [97, 116]. It is also important to recreate
all the motions at the ankle joint instead of just plantar flexion and dorsiflexion [97]. This
includes talar tilt as the ankle is coupled to the subtalar joint to accommodate to uneven
ground, and the rotational motion of internal rotation coupled to plantar flexion and ex‐
ternal rotation coupled to dorsiflexion. Failure to understand and recreate these motions
will place abnormal stress through the implant-bone interface [97]. It is critical to under‐
stand the necessity of ligament support for ankle stability [5]. An implant designed to be
sufficiently stable to negate the need for ligament support will transfer abnormal stress to
the bone-implant interface leading to loosening [94, 102, 103]. In contrast, an implant de‐
signed with low stability that  is  implanted into an ankle without sufficient  ligamentous
support will fail due to component mal-alignment or dislocation of the polyethylene [94,
97,  104,  105].  The requirement to  withstand high loads means that  ultra-high molecular
weight polyethylene is generally recommended [97, 117].
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Third generation ankle arthroplasties are now in use. The new designs show better under‐
standing of ankle biomechanics and allow for sliding and rotational movements [92]. There
are many different third generation implants used across the world and the following dis‐
cussion provides a representative sample of those commonly used in the Western world but
is not inclusive of all implants. The implants will be discussed in relation to design rationale.
The common surgical approach, as will be discussed in further detail later, is an anterior ap‐
proach in the interval between tibialis anterior tendon and extensor hallucis longus tendon.
The neurovascular bundle is carefully protected under the extensor hallucis longus tendon.
The major disadvantage of this approach is the high rate of wound healing complications
[92, 118, 119]. The BOX ankle replacement (Finsbury Orthopaedics, Leatherhead, Surrey,
UK) uses an anterolateral approach between the extensor digitorum longus tendon and the
peroneal tertius tendon [112]. The Eclipse (Integra LifeSciences, Plaisboro, NJ) is inserted
through either a medial (preferred) or lateral approach [112]. The disadvantage of this ap‐
proach is the need for fixation of the disrupted medial or lateral malleolus.
The current implants are either mobile (3 component design) or fixed (2 component design)
bearing [101]. Mobile bearing designs allow for greater congruence, which can increase the
risk of dislocation, but they share the stress through 2 articular surfaces, which may increase
weardue to “back side wear” [101, 120]. There is also the potential for “overstuffing” the
joint with three component designs in an attempt to reduce the chance of polyethylene dis‐
location [121]). Overstuffing tightens the joint, increases ligament strain, decreases range of
motion and increases the shear stress at the bone-prothesis interface [5, 121]. Fixed bearing
designs increase the constraint so they may have higher rates of loosening but have de‐
creased back side wear if the locking mechanism is intact [94, 101]. Current mobile bearing
designs include the STAR (Waldemar Link, Hamburg, Germany; 1978)(Figure 12), Buechel-
Pappas (Endotec, South Orange, NJ; 1989), Salto (Tornier, Saint Ismier, France; 1997), Hinte‐
gra (Integra LifeSciences/Newdeal, Lyon, France; 2002)(Figure 12), Mobility (DePuy
International, Leeds, UK; 2005)(Figure 12), BOX (Finsbury Orthopaedics, Leatherhead, Sur‐
rey, UK; 2005), CCI Evolution (Van Straten Medical, The Netherlands, 2007), and Zenith
(Corin, Cirencester, UK; 2009). Two component designs include the Agility (DePuy/Ace,
Warsaw, IN; 1985)(Figure 13), TNK (Kyocera, Kyoto, Japan; 1996), INBONE (Wright Medi‐
cal Technologies, Arlington, TN; 2005)(Figure 13), Salto Talaris (Tornier, Saint Ismier,
France; 2006), and Eclipse (Integra LifeSciences, Plainsboro, NJ; 2007).
Most ankle arthroplasty implants are constructed from cobalt-chromium alloys which are
hard, corrosion resistant and biocompatible (Hintegra, Agility, Mobility, Inbone talus, BOX,
Salto and Salto-Talaris, and Buechel-Pappas). The CCI Evolution adds molybdenum to the
alloy to increase strength (Van Straten Medical, The Netherlands, 2007). The STAR and In‐
bone (tibia only) use titanium implants which are softer but can be more porous to allow for
better ingrowth. The TNK is a ceramic implant (Kyocera, Kyoto, Japan; 1996).
Initial implants were cemented; however, due to the high rate of failure, most implants to‐
day are uncemented relying on bone ingrowth stimulated by hydroxyapatite coating, sin‐
tered metal beads, plasma spray metals or fiber metals [101]. The different methods to
encourage bony ingrowth include ensuring the metal is porous such as the Hintegra which
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is 20% porous [92]. Some implants, like the STAR, use a single or dual plasma spray. Others
use a thin film ceramic coating. The Buechel-Pappas and CCI Evolution use a porous coating
covered by a titanium nitride thin-film ceramic [92] which also improves the smoothness of
the surface. The Zenith uses the trademarked “BONIT” coating which is the application of a
thin calcium phosphate layer to the titanium plasma spray. The last common technique is
the use of hydroxyapatite incorporated in the Hintegra [92].
 
Figure 12. Radiographic images of three currently used mobile bearing total ankle arthroplasty designs. The top two
images are STAR, middle two images are Hintegra and the bottom two images are Mobility.
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 Figure 13. Radiographic images of two currently used fixed bearing total ankle arthroplasty designs. The left image is
Agility while the right two images are Inbone.
In most implants the tibial cut is made first. Unlike the knee, the ankle cannot be dislocated
sufficiently to allow for intramedullary guides to make the tibial cuts so all ankle arthroplas‐
ties, with the exception of the Inbone, use extramedully tibial guides with or without a foot
holder. The Inbone uses an external guide and radiographs to guide the insertion of an in‐
tramedullary reamer and combines it with a foot holder to place the tibial cutting guide
[112]. After the tibial cut has been completed and the intramedullary canal has been reamed,
the tibial stem and plate components are inserted one at a time into the joint and built inside
the ankle and tibia. The downside of using this intramedullary technique is that the subtalar
joint is violated as the tibial canal is reamed retrograde through the calcaneus, talus and
then tibia.
Other implants, such as the Buechel-Pappas, Mobility and Agility use intramedullary posts
on the tibia to provide fixation by creating an anterior cortical window to insert the tibial
component which is then replaced and generally heals without incident. If the tibial compo‐
nent does not have an intramedullary stem, the fixation can be with a fin (CCI Evolution), a
fin with a cylinder (Salto), double cylinders (STAR), bars (BOX) or an anterior shield which
may or may not be augmented with screws (Hintegra).
Tibial components can either rely on support from the intramedullary stem (Inbone) or cort‐
ical bone anteriorly and posteriorly (Hintegra). Some tibial components are rectangular and
others are trapezoidal designed to be larger anterior than posterior (STARand CCI Evolu‐
tion). Finally, while most are flat, they can be designed with a curve (BOX).
The design of the talus implant can be with a symmetrical curve (STAR, Buechel-Pappas,
INBONE, Mobility) or asymmetrical so that the radius of curvature for the medial side is
less  than that  for  the  lateral  side  (Salto,  Hintegra,  BOX,  CCI  Evolution).  Most  implants
resurface  the  talus  (STAR,  Buechel-Pappas,  Salto,  Hintegra,  Mobility,  BOX,  CCI  Evolu‐
tion,  and Zenith),  but  the Inbone and Agility  use a  flat  talar  cut.  Some designs replace
the medial and lateral talar articulations (STAR, Buechel-Pappas, TNK, Salto, and Hinte‐
gra)  while  others  do  not  (Agility,  BOX,  Mobility,  CCI  Evolution,  and  Zenith,).  Finally,
the polyethylene is  ultra-high molecular weight polyethylene in the STAR, Buechel-Pap‐
pas, Salto, Hintegra and Inbone.
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In summary, the third generation implants have been designed using the knowledge gained
from more indepth study of the anatomy and biomechanics of the ankle joint as well as the
causes of the failures of the first and second generation implants. When choosing an im‐
plant, the surgeon should consider the approach, the need for intramedullary guides and
fixation of the tibial component, the relative importance of preserving talar bone stock by
resurfacing the talus as opposed to a flat cut, the need for replacing the medial and lateral
articulations of the talus, and the role for ultra-high molecular weight polyethylene.
5. Surgical considerations
Clinical indications for total ankle arthroplasty include end stage ankle arthritis that has ex‐
hausted all non-operative and joint-sparing operative treatments in a patient willing to un‐
dertake the risks of a major surgical procedure. Contraindications to this procedure include:
• Active infection
• Compromised soft tissues
• Inadequate blood supply
• Peripheral neuropathy (including Charcot arthropathy)
• Significant lower extremity neuromuscular impairment
• Severe ligamentous laxity
• Excessive malalignment
• Avascular necrosis of a significant portion of the tibia or talus
• Severe osteoporosis
• Inadequate bone stock
• Skeletal immaturity
• High demand lifestyle
• Pertinent metal allergy
• Sensory or motor dysfunction
Age is not explicitly mentioned as a contraindication in the literature. The safe zone appears
to be somewhere after skeletal maturity and in conjunction with the assumption of a low de‐
mand lifestyle. Excessive malalignment is a nebulous term. The commonly accepted range is
from 15-20 degrees of varus or valgus to not surgically correctable. It would appear that ex‐
cessive malalignment is relative to the surgeon’s skill and experience. Obesity as a contrain‐
dication to total ankle arthroplasty is controversial and was not correlated to aseptic
loosening in a recent article [122].
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5.1. Surgical approach
There are several different types of ankle arthroplasty systems currently on the market as
discussed. Each system has unique features best explained by the surgical technique manual
provided by the company marketing that system. There are, however, certain common as‐
pects and principles of all of the systems which we will outline in this section.
5.2. Preoperative planning
The condition of the soft tissue envelope including locations of scars and documentation of
neurovascular status are important when planning a total ankle arthroplsty. Ankle arthro‐
plasty may be contraindicated in some cases due to an impaired soft tissue envelope or in‐
adequate blood supply to the foot.
Long leg weight-bearing views will help identify concurrent ipsilateral limb deformities
which may affect ankle alignment. Anteroposterior and lateral views of the tibia are also im‐
portant because intraoperative alignment is usually referenced off of the tibia. Weightbear‐
ing anteroposterior and lateral views of the ankle and foot are important to assess the joint
being replaced but also to identify coexisting deformities and/or arthritis affecting the rest of
the foot which may affect the surgical plan resulting in additional procedures that can be
performed in a staged manner or concurrently depending on surgeon skill and preference.
5.3. Positioning
The patient is positioned supine on a radiolucent table to allow fluoroscopic guidance of the
procedure. The ipsilateral hip is supported to prop the foot perpendicular to the floor to al‐
low easy access to both the medial and lateral aspects of the joint and enable evaluation of
alignment intraoperatively. Rotation of the foot relative to the leg on the contralateral side
should be noted before prepping and draping to determine what is normal for that patient.
5.4. Prepping and draping
A thigh tourniquet is utilized to provide hemostasis during the procedure. The leg is prep‐
ped and draped as a free extremity right up to the tourniquet to provide access to the knee.
Many total ankle arthroplasty systems use the length of the tibia and an external alignment
device as a guide to proper alignment.
5.5. Surgical exposure
The most common surgical approach to the ankle for insertion of a total ankle arthroplasty
is the anterior approach. Some systems that involve tibiofibular fusion as part of the proce‐
dure may require and an additional lateral incision but still utilize the anterior approach as
well. An incision is made over the anterior aspect of the ankle midway between the malleoli
(Figure 14). The incision needs to be long enough to allow placement of the distal tibial cut‐
ting block and visualization of the talar neck. Care is taken to minimize injury to the branch‐
es of the superficial and deep peroneal nerves. The retinaculum is then split to expose the
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underlying tendons. The extensor hallucis longus tendon will be retracted laterally to pro‐
tect the underlying neurovascular structures which should be located deep and lateral to the
extensor hallucis longus tendon (Figures 14 and 15). If possible, the sheath of the tibialis an‐
terior should be left intact to prevent undue pressure on the wound post-operatively (Figure
16). The anterior capsule is incised vertically and then peeled away in a subperiosteal plane
medially and laterally to expose the joint (Figure 17). One should be able to see the medial
malleolus clearly but the lateral malleolus is more posterior and often is not as easily seen.
Distal tibial osteophytes are now removed taking note of a commonly occurring large osteo‐
phyte anterior to the fibula. Care should be taken to differentiate the osteophyte from the
fibula itself. There will also be osteophytes on the neck of the talus which can be removed
with a curette, rongeur or burr to reestablish its normal contour. This will help with cutting
block placement and ankle positioning when cuts are made (Figure 18).
Figure 14. Anterior incision midway between the malleoli. Toes are to the left and knee is to the right. Blunt retractors
and extreme soft tissue care are required.
Figure 15. Exposure of the neurovascular bundle by retraction of the extensor hallucis longus tendon.
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Figure 16. Tibialis anterior sheath.
Figure 17. Exposure of the joint.
Figure 18. Anterior tibial osteophyte requires removal.
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The soft tissues should be handled with extreme caution. Blunt self-retaining retractors
should be repositioned periodically to prevent prolonged pressure on the soft tisse. Care
should be taken with the bone as well. Levering on the medial malleolus may result in frac‐
ture. Notching the fibula during the distal tibial resection can result in fracture as well. Ex‐
posure can be facilitated by instruments such as laminar spreaders, distractors and various
retractors. Performing the talar cuts can also facilitate removal of posterior malleolar frag‐
ments in systems that require this.
5.6. Alignment
The tibia is used to guide placement of the cutting blocks either with an external rod placed
parallel to the shaft of the tibia by direct visualization or overlapped with the tibial canal
fluoroscopically. The distal tibia is cut perpendicular to the anatomical axis of the tibia in the
coronal plane. Most systems build in a posterior slope to the distal tibial cut in the sagittal
plane and this can be adjusted in certain cases to allow more or less slope depending on the
patient‘s needs. Longitudinal alignment of the talar component is usually in line with the
second ray of the foot.
5.7. Ligamentous balancing
Ligamentous balancing is not yet as sophisticated as for total knee arthroplasty. The posteri‐
or capsule is resected during the removal of the posterior malleolus. Medially, the deltoid
ligament can be released in a subperiosteal plane from the medial malleolus and/or talus,
pie-crusted, released mid-substance or relatively lengthened through a medial malleolar os‐
teotomy [123-126]. Laterally, the talofibular ligaments should be treated with care. Aggres‐
sive release from the talus can result in iatrogenic lateral instability. If there is a preexisting
lateral instability, consent should be obtained for a lateral ligament reconstruction if re‐
quired. Generally, stability is assessed after the bony cuts are made. A gastrocsoleus slide or
Achilles tendon lengthening may be required if the ankle does dorsiflex past neutral after
the ankle arthroplasty has been performed.
5.8. Closure
Repair of the extensor retinaculum during closure is very important. If left uncovered, the
tibialis anterior may erode through the incision putting the arthroplasty and possibly even
the leg at risk.
5.9. Post-op care
In the case of an uncomplicated ankle arthroplasty with no extra ligament reconstruction or
fusion the patient has a short period of non-weight-bearing activity in a splint or cast fol‐
lowed by weight-bearing activity in a cast until the six week post-operative visit. Subse‐
quently, physiotherapy to work on dorsiflexion and plantar flexion, gait retraining and leg
strengthening is initiated.
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There are no guidelines in regards to deep venous thrombosis (DVT) prophylaxis after total
ankle arthroplasty but it would prudent to use propylaxis in patients with significant risk
factors. Obesity, previous venous thromboembolism, and absence of full postoperative
weightbearing were identified as risk factors for the development of DVT in a study on total
ankle arthroplasty in the obese [122]. The importance of these risk factors was echoed by
Barg et al in their article looking at risk factors for DVT in total ankle arthroplasty patients
who were give thromboprophylaxis [127]. Other factors associated with increased incidence
of DVTs include cancer, use of high dose estrogen replacement, and smoking.
5.10. Radiological follow-up
Ankle replacements should be followed radiologically as well as clinically in the post-opera‐
tive period including weightbearing anteroposterior and lateral x-rays. One should look for
changes in position which would indicate loosening of the components. Persistent peripros‐
thetic lucencies should be followed for progression. There are a variety of angular measure‐
ments based on anatomical axes and component position as well as standardized distances
from anatomical landmarks to component landmarks that can be used to assess technical
success of prostheses implantation or subsequent subsidence [128].
5.11. Complications
The complications associated with total ankle arthroplasty would be familiar to any should‐
er, hip or knee arthroplasty surgeon. and can be classified in different ways. Glazebrook et
al recently published an evidence-based classification system that groups complications ac‐
cording to their correlation with failure of the prosthesis [3]. The goal of this classification
system is to provide prognostic information to help surgeons deal with complications more
effectively. To develop this classification system, the current literature on second and third
generation prosthetic ankle arthroplasty outcomes were reviewed. Based on this informa‐
tion they were able to provide a summary of total ankle arthroplasty implant survival and
complication rates. Twenty studies met their inclusion criteria with follow-up periods rang‐
ing from two to twelve years. In total 2,386 ankle arthroplasties were reviewed. They report‐
ed nine main complications including:
• Subsidence – 10.7%
• Aseptic loosening – 8.7%
• Intra-op fracture – 8.1%
• Wound healing problem – 6.6%
• Technical error – 6.0%
• Implant failure – 5.0%
• Non-union – 4.4%
• Post-op bone fracture – 2.0%
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• Deep infection – 1.7%
These complications were compiled into three groups depending on how likely the compli‐
cation would lead to failure of the arthroplasty. The three complications that lead to arthro‐
plasty failure greater than 50% of the time were deep infection, aseptic loosening and
implant failure. Other complications not included in this review that should be noted in‐
clude tendon laceration, nerve injury, and instability (due to ligamentous imbalance). Im‐
pingement is another complication that is minor in terms of prosthesis survival but can have
a significant effect in terms of patient satisfaction. It is usually medial and can be caused by
osteophytes, scar tissue or tibialis posterior tendon degeneration.
5.12. Outcomes
In order to evaluate the outcomes of contemproary total ankle arthroplasty, it is instructive
to look at the results published by joint registries from around the world. While not as com‐
mon as registries for total hip and knee arthroplasty, there are at least four registries report‐
ed in the literature.
In 2007 the Norwegian registry reported on their experiences with total ankle arthroplas‐
ty [129]. This registry looked at 257 joints implanted between 1994 and 2005. This includ‐
ed a  small  number  of  cemented implants.  The  average  age  at  the  time of  implantation
was 58  for  women and 60  for  men.  The The 5-year  survival  rate  was 89% and the  10-
year survival rate was 76%. There was no difference in the survival rates of the cement‐
ed and cementless prostheses.
The New Zealand registry reported on 202 joints in total also in 2007 [130]. This included
both second and third generation prostheses. The average age of the patients at the time of
implantation was 65. The most common diagnosis was primary osteoarthritis. The 5-year
survival rate was 86%.
In 2010 the Finnish registry published their results on 573 total ankle arthroplasties [131].
These were all third-generation mobile-bearing designs. The average age of the patients was
55. The 5-year survival was 83%.
The Swedish Registry reported on the ten year survival of 780 third-generation total an‐
kle arthoplasties in 2011 [132]. The registry included a variety of uncemented, three com‐
ponent implants. Revision rate was used as the primary outcome variable. The overall 10
year survival rate was 69% although this increased to 78% of the STAR prostheses were
excluded. It is interesting to note that the other registries did include the STAR prosthe‐
ses in their results.
Overall, age, sex, and diangosis did not affect survival in the Norwegian, New Zealand or
Finnish registries. The Swedish registry, however, found that the risk for revision was high‐
er in female patients under 60 years of age with a diagnosis of primary osteoarthritis or
posttraumatic arthritis.
There have been a lot of outcome studies published in recent years but a disproportion‐
ate number have been published by the prostheses designers themselves according to La‐
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bek  et  al  [133].  Approximately  50%  of  the  publications  reporting  on  total  ankle
arthroplasty outcomes have been produced by implant developers. Furthermore, the revi‐
sion  rates  from the  national  registries  (Swedish,  Norwegian  and  New Zealand)  have  a
much higher revision rate than those published in peer-reviewed scientific  journals  that
include the manufacturers‘ reports [133].
That said, it is still worthwhile to look at all of the published data. There have been three
relatively recent reviews of total ankle arthroplasty outcome study data [69, 134, 135]. The
most recent one was published by Gougoulias et al in 2010 [134]. They included thirteen
Level IV studies looking at 1105 total ankle arthroplasties. The most common diagnosis was
posttraumatic arthritis. The overall failure rate was approximately 10% at 5 years. Range of
motion did not change in one study and improved by 4-14 degrees in four others. In the
studies reporting them, there were superficial wound complications in 0-14%, and deep in‐
fections in 0-4.6%. In seven studies, rates of residual pain in the hindfoot ranged from 23 to
60%. Interestingly, the most common sporting activities after total ankle arthroplasty were
identified as swimming, cycling and fitness/weight training.
In an older review published in 2007 by Haddad et al, the intermediate outcomes of total
ankle arthroplasty and ankle fusion were compared [69]. They looked at ten papers which
evaluated total ankle arthroplasty and thirty-nine which looked at ankle fusion. The mean
American Orthopaedic Foot and Ankle Society Ankle Hindfoot score was 78.2 for the ar‐
throplasty group and 75.6 for the fusion group. The average age of patients undergoing ar‐
throplasty was 58 and fusion 50. The majority of the fusion patients were male, while the
major of the arthroplasty patients were female. Rheumatoid arthritis was the primary indi‐
cation for total ankle arthroplasty, posttraumatic arthritis for fusion. The 5-year implant sur‐
vival rate for the arthroplasty group was 90%, while the 10-year survival rate was 77%. They
noted that a weakness of their review was that there were no direct comparisons of total an‐
kle arthroplasty to ankle fusion.
Stengel et al’s review in 2005 identified 10 adequate studies with a total of 497 ankle arthro‐
plasties [135]. The total ankle arthroplasty patients showed a mean improvement in hindfoot
scores of 45.2 points. Range of motion improved an average of 6.3%. Complications ranged
from a 1.6% deep infection rate to a 14.7% impingement rate. The five year prosthesis sur‐
vival rate was 90.6%.
Since the publication of the most recent of the above reviews, there have been some other
publications of note. The long-term results of the United States STAR trial were published in
2011 [136]. They prospectively followed 80 patients treated with 84 STAR prostheses. The
average age at implantation was 61 years. Their American Orthopaedic Foot and Ankle Soci‐
ety ankle-hindoot scores improved from an average of 42.7 to 81.9 points. Average range of
motion was 39.5 degrees. Implant survival was 96% at 5 years and 90% at 10 years.
Bonnin et al recently published the long term follow-up of patients they had implanted with
the SALTO total ankle arthroplasty and reported on previously [137]. They analyzed 98
prostheses with and average followup of 8.9 years. The mean American Foot and Ankle So‐
ciety ankle-hindfoot score was 79. Range of motion was 27 degrees. The survival rate was
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85% with an end point being the revision of a component. Limitations of this study included
the series of patients being operated on by the implant designers and the implants and tech‐
nique changed during the course of the study.
Wood et al compared the STAR implant to the Buechel-Pappas implant in a randomised tri‐
al [138]. The study involved 200 joint replacements. They were followed out for 6 years. The
STAR survivorship was 95% and the Buechel-Pappas 79% with the end point being revision.
The difference was not found to be statistically different.
Total ankle arthroplasty has been shown to improve ankle joint mechanics. Hahn et al dem‐
onstrated that both arthroplasty and fusion impoved gait function and reduced pain but
that arthroplasty patients gained a more natural ankle joint function with increased range of
motion [139]. Piriou et al were also interested in how gait was affected by total ankle arthro‐
plasty [140]. They compared 12 arthroplasty patients to 12 fusion and 12 control patients.
Neither the arthroplasty patients nor the fusion patients regained normal movement or
walking speed, but the arthroplasty group had greater movement at the ankle, more sym‐
metrical timing of gait and better restored ground reaction force patterns than the fusion
group. The fusion group had a faster gait and longer step length than the arthroplasty
group. Schuh et al compared 21 ankle fusion patients to 20 total ankle arthroplasty patients
in regards to sport and recreational activities as well as functional outcome directly [89].
They found no signifcant difference between the groups concerning activity levels, partici‐
pation in sports activities.
Finally,  despite  improved motion and decreased pain,  total  ankle  arthroplasty  does  not
result  in weight loss.  Penner at  al  investigated weight loss after total  ankle arthroplasty
and found that although pain and disability were reduced in overweight and obese pa‐
tients  after  both  ankle  arthroplasty  and  fusion,  the  mean  body  mass  index  (BMI)  re‐
mained unchanged [141].
6. Conclusion
Ankle arthritis can be a debilitating disorder as disabling mentally and physically as hip ar‐
thritis. There are a myriad of nonoperative and joint sparing operative treatments that can
improved symptoms but do not arrest the disease process. When end-stage osteoarthritis
develops, the gold standard has been ankle fusion. Some limitations to a successful ankle fu‐
sion such as stiffness and arthritic progression of surrounding joints as well as the successful
replacements of the hip and knee joint led to the development of total ankle arthroplasty.
Second and third generation prostheses have markedly improved function and long-term
results compared to first generation prostheses. Although the procedure can be technically
demanding and is associated with numerous potential complications, patients generally ex‐
perience improved function and decreased pain. Based on current literature, it seems rea‐
sonable to expect an 80% prosthesis survival after 10 years. Further investigations into ankle
joint mechanics, risk factors for implant failure and methods to minimize complications
should lead to additional improvements in long-term outcomes. Finally, prospective, long-
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term direct comparison studies of ankle fusion versus total ankle arthroplasty are required
to determine which procedure is best for which patient.
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